Hans Messner Allogeneic BMT Program
@hans_bmtprogram
Official account of the Hans Messner Allogeneic Blood and Marrow Transplant Program at Princess Margaret Hospital, Toronto. Posts are not medical advice.
ID: 1238128592434778112
https://www.uhn.ca/PrincessMargaret/Clinics/Allogeneic_Transplant 12-03-2020 15:44:10
125 Tweet
198 Followers
82 Following
In 2024, we performed close to 250 allogeneic transplants!! Thank you to our patients and every member of the exceptional team ๐๐ฝ Bring on 2025 ๐ช๐ฝ #MedTwitter Hans Messner Allogeneic BMT Program
An allogeneic stem cell transplant uses donor stem cells to treat cancer. People who will have an allogeneic stem cell transplant and their loved ones can learn about the process in this eLearning series. pmcancerclasses.ca/course/view.phโฆ Hans Messner Allogeneic BMT Program
I am pleased to present 3 posters and chair a session at The EBMT annual meeting in Florence ๐๐ฝ Can't wait to meet the mad lot we call The EBMT Trainee Committee ๐คฃ๐คฃ Hans Messner Allogeneic BMT Program #MedTwitter
This eLearning series explains the process of allogeneic stem cell transplant to treat sickle cell disease. pmcancerclasses.ca/course/view.phโฆ Hans Messner Allogeneic BMT Program
Wow! What a phenomenal team we work with at Hans Messner Allogeneic BMT Program ! It truly takes a village to achieve such a monumental goal.
Huge milestone! Today our centre infused the 200th AlloBMT for this fiscal year. Thatโs 200 Allogeneic Stem Cell Transplants THIS YEAR (overall weโre >5k) and weโre still going strong! A new record! #AlloBMT #bmtsm Princess Margaret Cancer Centre University Health Network ๐ก๐ถ๐ต๐ฎ๐ฟ ๐๐ฒ๐๐ฎ๐ถ MD, DM Brad Wouters ๐จ๐ฆ The Princess Margaret Cancer Foundation
๐๐ 200 ALLOGENEIC transplants in a year is no mean feat ๐ช๐ฝ๐ช๐ฝ๐ช๐ฝ๐ช๐ฝ๐ช๐ฝ๐ช๐ฝ I am proud to be a part of this amazing team ๐ช๐ฝ P.S. We are on track for 250 this year ๐๐ฝ #MedTwitter Arjun D. Law Hans Messner Allogeneic BMT Program Pankti Mehta Sergio Rodrรญguez-Rodriguez, MD, MSc. ๐ฒ๐ฝ Nico Gagelmann
๐๐๐Excited to have TWO ORAL PRESENTATIONS at #ASCO25 in Chicago! As always, I'm thankful to Arjun D. Law and the team at Princess Margaret Cancer Centre for the phenomenal mentorship ๐๐ฝ Looking forward to a great discussion and meeting some solid oncologists ๐คฃ #MedTwitter
The abstract titles for #ASCO25 are out ๐๐ฝ We asked 2 questions: 1. Can we โคต๏ธthe PTCy dose in MUDs? 2. What's the outcome of patients who are alive 2 yr post transplant? We'll answer those questions at the oral abstract session ASCO #MedTwitter Hans Messner Allogeneic BMT Program
๐จ New Study Alert! ๐ก๐ถ๐ต๐ฎ๐ฟ ๐๐ฒ๐๐ฎ๐ถ MD, DM Arjun D. Law Ivan Pasic Our team retrospectively analyzed our cohort on allogeneic HSCT outcomes in patients with MDS/MPN overlap syndromesโa rare and challenging group of hematologic neoplasms. ๐งต๐
Excellent thread summarising key findings of our latest publication from Princess Margaret Cancer Centre ๐๐ฝ DM me if you want the PDF ๐๐ฝ onlinelibrary.wiley.com/doi/10.1111/ejโฆ #MedTwitter Sergio Rodrรญguez-Rodriguez, MD, MSc. ๐ฒ๐ฝ Hans Messner Allogeneic BMT Program Arjun D. Law
Proud moment at the CTTC Conference! Hereโs a roundup of phenomenal poster presentations from our team at Hans Messner Allogeneic BMT Program University Health Network and Princess Margaret Cancer Centre , tackling real-world challenges in transplant medicine and GVHD. #CTTC2025 #HCT #GVHD #HemeTwitter 1/10
Delighted to share our latest publication on the impact of conditioning intensity in younger AML patients receiving dual T-cell depletion for GVHD prophylaxis. #Hematology #BMT Ahmed AlNughmush Hans Messner Allogeneic BMT Program doi.org/10.1111/ejh.14โฆ
๐ Out now in Transplantation and Cellular Therapy Journal ๐๐ฝ We compare two conditioning regimens for second allogeneic transplant after primary graft failure! Interesting results ๐๐ฝ DM me for the PDF! sciencedirect.com/science/articlโฆ Hans Messner Allogeneic BMT Program
Our work is now out in Transplantation and Cellular Therapy Journal We looked into the association between cumulative cyclosporine exposure over the first 90 days (AUC90) post-HCT and key transplant outcomes, including graft failure and relapse. Hans Messner Allogeneic BMT Program astctjournal.org/article/S2666-โฆ
An allogeneic stem cell transplant uses donor stem cells to treat cancer. People who will have an allogeneic stem cell transplant and caregivers can learn about the process in this eLearning series. Hans Messner Allogeneic BMT Program pmcancerclasses.ca/course/view.phโฆ
๐ข Published in Transplantation and Cellular Therapy Journal ๐ Using a large dataset (CIBMTR + Hans Messner Allogeneic BMT Program), we show that ATG + PTCy may alleviate the โคด๏ธGvHD risk associated with female donor-to-male recipient MUD transplants ๐๐ฝ astctjournal.org/article/S2666-โฆ
๐ข Now out in British Journal of Haematology ๐๐ Our latest work from the Princess Margaret Cancer Centre explores how GvHD prophylaxis influences the risk of second primary malignancies after allogeneic transplants using a large cohort of 1,418 patients (>6000 person-years of follow up) onlinelibrary.wiley.com/doi/10.1111/bjโฆ
